GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Prenetics Global Ltd (NAS:PRE) » Definitions » Enterprise Value
中文

Prenetics Global (Prenetics Global) Enterprise Value

: $-18.9 Mil (As of Today)
View and export this data going back to 2022. Start your Free Trial

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Prenetics Global's Enterprise Value is $-18.9 Mil. Prenetics Global's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 was $-7.6 Mil. Therefore, Prenetics Global's EV-to-EBIT ratio for today is 2.50.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Prenetics Global's Enterprise Value is $-18.9 Mil. Prenetics Global's EBITDA for the trailing twelve months (TTM) ended in Sep. 2023 was $-7.6 Mil. Therefore, Prenetics Global's EV-to-EBITDA ratio for today is 2.50.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Prenetics Global's Enterprise Value is $-18.9 Mil. Prenetics Global's Revenue for the trailing twelve months (TTM) ended in Sep. 2023 was $291.4 Mil. Therefore, Prenetics Global's EV-to-Revenue ratio for today is -0.06.


Prenetics Global Enterprise Value Historical Data

The historical data trend for Prenetics Global's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Prenetics Global Annual Data
Trend Dec19 Dec20 Dec21 Dec22
Enterprise Value
- - - 122.81

Prenetics Global Quarterly Data
Dec19 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 293.28 122.81 -19.01 -19.39 28.19

Competitive Comparison

For the Diagnostics & Research subindustry, Prenetics Global's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Prenetics Global Enterprise Value Distribution

For the Medical Diagnostics & Research industry and Healthcare sector, Prenetics Global's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Prenetics Global's Enterprise Value falls into.



Prenetics Global Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Prenetics Global's Enterprise Value for the fiscal year that ended in Dec. 2022 is calculated as

Prenetics Global's Enterprise Value for the quarter that ended in Sep. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Prenetics Global  (NAS:PRE) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Prenetics Global's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=-18.917/-7.569
=2.50

Prenetics Global's current Enterprise Value is $-18.9 Mil.
Prenetics Global's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-7.6 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Prenetics Global's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=-18.917/-7.569
=2.50

Prenetics Global's current Enterprise Value is $-18.9 Mil.
Prenetics Global's EBITDA for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-7.6 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Prenetics Global's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=-18.917/291.437
=-0.06

Prenetics Global's current Enterprise Value is $-18.9 Mil.
Prenetics Global's Revenue for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $291.4 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Prenetics Global Enterprise Value Related Terms

Thank you for viewing the detailed overview of Prenetics Global's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Prenetics Global (Prenetics Global) Business Description

Traded in Other Exchanges
N/A
Address
Unit 701-706, K11 Atelier King’s Road, 728 King’s Road, Quarry Bay, Hong Kong, HKG
Prenetics Global Ltd is a diagnostic and genetic testing company. It is a genomics and precision oncology company that has devised a method to integrate early detection for cancer, targeted therapy and direct-to-consumer genetic testing services into one comprehensive platform. It operates in two segments. The prevention segment includes the design & sale of genetics testing (including update services) & stool-based DNA tests for early colorectal cancer screening. The diagnostic segment includes the sale of COVID-19 testing services & products and precision oncology services. The majority of revenue is from the diagnostics segment. Geographically, it operates in Hong Kong and the United Kingdom, out of which the majority is from Hong Kong.